Paediatric Consumer Health in China

Paediatric consumer health is set to maintain solid although slower retail current value growth in China in 2024, and it is projected to maintain a high single-digit CAGR moving forward, with continued upgrades in consumer preferences when it comes to paediatric products. Despite a declining birth rate, the increasing focus on child care has highlighted significant potential for paediatric vitamins and dietary supplements in particular, which is set to see above-average growth in China in 2024.

The Paediatric Consumer Health in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Paediatric Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.